share_log

BMO Capital Upgrades Chemours to Outperform, Raises Price Target to $34

BMO Capital Upgrades Chemours to Outperform, Raises Price Target to $34

BMO Capital將Chemours上調至跑贏大盤,將目標股價上調至34美元
Moomoo 24/7 ·  04/09 05:48

BMO Capital analyst John McNulty upgrades Chemours (NYSE:CC) from Market Perform to Outperform and raises the price target from $19 to $34.

BMO Capital分析師約翰·麥克納爾蒂將Chemours(紐約證券交易所代碼:CC)從市場表現上調至跑贏大盤,並將目標股價從19美元上調至34美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論